The putative "silent" 5-HT1A receptor antagonist, WAY 100635, has inverse agonist properties at cloned human 5-HT1A receptors

被引:32
|
作者
Cosi, C [1 ]
Koek, W [1 ]
机构
[1] Ctr Rech Pierre Fabre, Div Neurobiol 2, F-80106 Castres, France
关键词
S-35]GTP gamma S binding; 5-HT1A receptor; inverse agonist; WAY; 100635;
D O I
10.1016/S0014-2999(00)00410-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Agonist binding to G protein-coupled receptors induces the formation of a receptor-G protein complex and subsequent guanosine 5'-diphosphate/guanosine 5'-triphosphate (GDP/GTP) exchange. Some receptors, however, form receptor-a protein complexes and promote GDP/GTP exchange even when not occupied by agonists. Such receptors preferentially activate pertussis toxin-sensitive G proteins (i.e., G(i)/G(o)), and the interactions of receptors and G proteins are affected by monovalent cations (most notably Na+), both in the occupied and unoccupied state. We investigated the effects of Na+ on the intrinsic activity of 5-hydroxytryptamine,. (5-HT1A) receptor ligands, measured as maximal effect (E-MAX), using guanosine 5'-0-(3-[S-35]thio)-triphosphate ([S-35]GTP gamma S) binding to membranes prepared from human epithelioid carcinoma (HeLa) cells, expressing 500 fmol/mg protein of cloned human 5-HT1A receptor (HA7 cells). A decrease of the NaCl concentration decreased the maximal effect of serotonin, increased basal [S-35]GTP gamma S binding, and increased the negative intrinsic activity of spiperone and N-[2-[4-(2-methoxyphenyl)-1-piperazinyl]-N-(2-pyridinyl)cyclohexanecarboxamide (WAY 100635). This ability of WAY 100635 to decrease basal [S-35]GTP gamma S binding was antagonized by (s)-N-tert-butyl-3-(4-(2-methaxyphenyl)piperazine-1-yl)-2-phenylpropanamide ((s)-WAY 100135) (pA(2) = 7.77). Further, WAY 100635 was able to antagonize carboxamidotryptamine (5-CT)-stimulated [S-35]GTP gamma S binding with a pA(2) of 9.9, in standard NaCl conditions, and of 9.7, in the absence of NaCl. Changes in membrane concentration did not affect the ability of WAY 100635 to decrease [S-35]GTP gamma S binding. WAY 100635 did not affect basal [S-35]GTP gamma S binding to membranes from untransfected HeLa cells. Pertussis toxin (200 ng/ml) prevented WAY 100635 and spiperone to decrease [S-35]GTP gamma S binding, showing that their effects were mediated by G proteins of the G(i)/G(o) family. In conclusion, the constitutive and stimulated activity of human 5-HT1A receptors expressed in HA7 cells is sodium-dependent, which allowed to confirm the 5-HT1A inverse agonist properties of spiperone, and to show that WAY 100635 is an inverse agonist at 5-HT1A receptors that inhibits basal [S-35]GTP gamma S binding to a lesser extent than spiperone. [S-35]GTP gamma S binding to membranes from HA7 cells under low NaCl conditions appears to be especially suitable to evidence and pharmacologically analyze the inverse agonist properties of 5-HT1A receptor ligands. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:9 / 15
页数:7
相关论文
共 50 条
  • [1] A PHARMACOLOGICAL PROFILE OF THE SELECTIVE SILENT 5-HT1A RECEPTOR ANTAGONIST, WAY-100635
    FORSTER, EA
    CLIFFE, IA
    BILL, DJ
    DOVER, GM
    JONES, D
    REILLY, Y
    FLETCHER, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1995, 281 (01) : 81 - 88
  • [2] Fluoroalkyl Derivatives of the 5-HT1A Antagonist WAY 100635
    Wilson, A. A.
    DaSilva, J. N.
    Houle, S.
    Journal of Labelled Compounds and Radiopharmaceuticals,
  • [3] Antagonist properties of (-)-pindolol and WAY 100635 at somatodendritic and postsynaptic 5-HT1A receptors in the rat brain
    Corradetti, R
    Laaris, N
    Hanoun, N
    Laporte, AM
    Le Poul, E
    Hamon, M
    Lanfumey, L
    BRITISH JOURNAL OF PHARMACOLOGY, 1998, 123 (03) : 449 - 462
  • [4] Clozapine is a partial agonist at cloned, human serotonin 5-HT1A receptors
    NewmanTancredi, A
    Chaput, C
    Verriele, L
    Millan, MJ
    NEUROPHARMACOLOGY, 1996, 35 (01) : 119 - 121
  • [5] The putative 5-HT1A receptor antagonist DU125530 blocks the discriminative stimulus of the 5-HT1A receptor agonist flesinoxan in pigeons
    Mos, J
    VanHest, A
    VanDrimmelen, M
    Herremans, AHJ
    Olivier, B
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 325 (2-3) : 145 - 153
  • [6] ANTAGONISM OF PRESYNAPTIC AND POSTSYNAPTIC 5-HT1A RECEPTORS INVIVO BY THE SELECTIVE 5-HT1A RECEPTOR ANTAGONIST, WAY100135
    ROUTLEDGE, C
    GURLING, J
    FORSTER, EA
    WRIGHT, I
    FLETCHER, A
    DOURISH, CT
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 : P5 - P5
  • [7] In vitro activity of chiral analogs of the serotonin 5-HT1A silent antagonist WAY-100635.
    Lenicek, S
    Kelly, MG
    Childers, WE
    Greenblatt, L
    Sabb, A
    Zhang, G
    Palmer, Y
    Podlesny, E
    Vogel, R
    Smith, DL
    Schechter, LE
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2000, 220 : U557 - U557
  • [8] Agonist, antagonist, and inverse agonist properties of antipsychotics at human recombinant 5-HT1A receptors expressed in HeLa cells
    Cosi, C
    Koek, W
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 433 (01) : 55 - 62
  • [9] Effect of 8-hydroxy-DPAT, a 5-HT1A agonist and way 100635, a 5-HT1A antagonist on the micturition reflex in the spinal cord injured cat
    Miscik, CL
    Taj, C
    Roppolo, J
    Ungerer, T
    De Groat, W
    JOURNAL OF UROLOGY, 2003, 169 (04): : 371 - 371
  • [10] Analogues of WAY 100635 as radiotracers for in vivo imaging of 5-HT1A receptors
    Wilson, AA
    Garcia, A
    Li, J
    DaSilva, JN
    Houle, S
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 1999, 42 (07): : 611 - 620